CDEK
← All organizations

Syntimmune, Inc.

For profit

Also known as: Syntimmune, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 1

First clinical trial

Aug 17, 2016

Last known activity

Apr 1, 2017

Acquired by Alexion → AstraZeneca on Sep 26, 2018

Timeline

2010s

  1. Jan 1, 2013

    Syntimmune, Inc.— Founded

  2. Sep 26, 2018

    Alexion— Acquired By

2020s

  1. Oct 13, 2020

    AstraZeneca— Now

Drugs by trial phase (1 distinct, 3 trials)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (3)

Details

Founded
Boston, MA, US Jan 1, 2013
Last known activity
Apr 1, 2017